BudCapital
Short

Specialty drug manufacturer - 3rd round of put buying

NYSE:VRX   VALEANT PHARMACEUTICALS INTL I
53 0 1
$VRX estimated report date is feb 22nd. Options market is pricing in a 15% move. Implied volatility is fairly high but this is the 3rd round of put buying I have noticed in the last month. Watching for a strong volume breakdown.
Ideas Scripts Chart
United States
United Kingdom
India
España
France
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out